申请人:City of Hope
公开号:US10787664B2
公开(公告)日:2020-09-29
The present disclosure relates to isolated compounds including a nucleic acid sequence capable of hybridizing to an RNA sequence 10 to 270 nucleobases downstream of the transcription start site of a mammalian microRNA-379 transcript; method of treating diabetic nephropathy in a subject with the compounds; and method of inhibiting expression of a mammalian microRNA-379 megacluster with the compounds.
本公开涉及分离的化合物,包括能够与哺乳动物microRNA-379转录本转录起始位点下游10至270个核碱基的RNA序列杂交的核酸序列;用这些化合物治疗受试者糖尿病肾病的方法;以及用这些化合物抑制哺乳动物microRNA-379巨簇表达的方法。